Compounds > phenylacetylglutamine
Page last updated: 2024-08-26

phenylacetylglutamine and Left Ventricular Dysfunction

phenylacetylglutamine has been researched along with Left Ventricular Dysfunction in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bäckhed, F; Buffa, JA; Castel, L; Deb, A; Demuth, I; DiDonato, JA; Haghikia, A; Hazen, SL; König, M; Landmesser, U; Li, L; Li, XS; Lovano, B; Menge, CM; Mohan, ML; Naga Prasad, SV; Nemet, I; Prasad Saha, P; Romano, KA; Steinhagen-Thiessen, E; Sun, Y; Tang, WHW; Van Wagoner, DR; Witkowski, M1

Trials

1 trial(s) available for phenylacetylglutamine and Left Ventricular Dysfunction

ArticleYear
Gut Microbiota-Generated Phenylacetylglutamine and Heart Failure.
    Circulation. Heart failure, 2023, Volume: 16, Issue:1

    Topics: Animals; Gastrointestinal Microbiome; Heart Failure; Humans; Mice; Natriuretic Peptide, Brain; Stroke Volume; Ventricular Dysfunction, Left; Ventricular Function, Left

2023